PSDV (MC $80 M) PDUFA Date on October 17 for Blockbuster Drug + Low Float = 500% Pote

[Biotechmaster]

Your big Opp to make quick money with upcoming FDA decision . GL

This Low Float Stock has the Potential to hit $6++ before FDA decision on October 17 and could move into double digits easily with FDA approval for Blockbuster Candidate Iluvien .There is NO FDA approved drugs for DME (Diabetic Macular Edema) .

Upon US approval of Iluvien, pSivida would be entitled to receive a $25 million milestone payment from Alimera and 20 percent of net profits, as defined, on sales of the drug by Alimera.

DME is a potentially blinding disease that affects over one million people in the United States. Currently there are no FDA approved drugs for the treatment of DME.The U.S. market for DME is $1.5 billion to $4 billion.

Iluvien was launched commercially in the United Kingdom and Germany in April and May 2013, respectively, and Alimera expects to launch Iluvien in France in the first quarter of 2014.

Psivida (PSDV)

Market Cap: $83 M
Cash: $24 M
Price: $3.56

Shares Out: 26.8 M ( 10.4 M shares held by Insiders & Institutions)



Slide Presentation (July 2013)



From latest Q-results :